Medicine and Dentistry
Abacavir
8%
Acquired Immune Deficiency Syndrome
5%
Acute Respiratory Distress Syndrome
13%
Antiinfective Agent
5%
Antiretroviral Therapy
9%
Booster Dose
5%
Bronchiolitis
5%
Cancer
5%
Cardiovascular Disease
18%
Cataract Surgery
5%
Cell Count
10%
Clinical Finding
5%
Cohort Analysis
42%
Common Variable Immunodeficiency
12%
COVID-19
29%
COVID-19 Vaccine
5%
Cryptococcal Meningitis
5%
Decision Making
11%
Deterioration
11%
Diabetes Mellitus
11%
Diagnosis
5%
Disease
24%
Disease Severity
5%
Drug Prescription
5%
Echography
8%
Epstein-Barr Virus
5%
Hepatitis C
12%
Hepatitis C Virus
17%
Highly Active Antiretroviral Therapy
15%
Human Immunodeficiency Virus
94%
Human Immunodeficiency Virus 1
5%
Human Immunodeficiency Virus Infection
18%
Immune Deficiency
6%
Immunodeficiency
5%
Infection
15%
Integrase
5%
Intensive Care Unit
11%
Interleukin 21
5%
Lung Function Test
6%
Mixed Infection
7%
Neutralizing Antibody
5%
Outpatient
5%
Pneumocystis Pneumonia
5%
Population
6%
Primary Health Care
12%
Prospective Cohort Study
5%
Prospective Study
5%
Severe Acute Respiratory Syndrome Coronavirus 2
26%
Thorax Radiography
5%
Venous Thromboembolism
5%
Pharmacology, Toxicology and Pharmaceutical Science
Abacavir
13%
Acquired Immune Deficiency Syndrome
6%
Adult Respiratory Distress Syndrome
11%
Allergic Reaction
5%
Cancer Incidence
5%
Cardiovascular Disease
25%
Cataract
5%
Cerebral Toxoplasmosis
5%
Chronic Kidney Failure
8%
Cohort Study
28%
Common Variable Immunodeficiency
28%
Comorbidity
5%
Coronavirinae
10%
COVID-19 Vaccine
16%
Deterioration
5%
Diabetes Mellitus
11%
Disease
22%
Heart Infarction
6%
Hematologic Malignancy
5%
Hepatitis C
21%
Hepatitis C Virus
23%
HIV
96%
Human Immunodeficiency Virus Infection
11%
Infection
21%
Integrase
11%
Malignant Neoplasm
5%
Mixed Infection
7%
Neutralizing Antibody
5%
Prevalence
7%
Prospective Study
5%
Psychotropic Agent
5%
SARS Coronavirus
31%
Toxoplasmosis
5%
Vaccination Policy
8%
Virus RNA
5%
Immunology and Microbiology
Antibody Response
5%
Antibody-Dependent Cell-Mediated Cytotoxicity
5%
Booster Dose
5%
CD4 Lymphocyte Count
9%
Cell Function
5%
Common Variable Immunodeficiency
23%
Comorbidity
7%
COVID-19
18%
Epstein Barr Virus
5%
Hepatitis C
5%
Hepatitis C Virus
5%
High Risk Population
6%
HIV/AIDS
5%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
6%
Hybrid Immunity
5%
Hypersensitive Response
5%
Hypogammaglobulinemia
6%
Immunodeficiency
13%
Inflammatory Arthritis
5%
Integrase
5%
Interleukin 21
5%
Monospecific Antibody
8%
Mortality Rate
9%
Mycoplasma hominis
5%
Natural Killer Cell
5%
Neutralizing Antibody
5%
Polymerase Chain Reaction
5%
Population
5%
Prevalence
7%
Septic Arthritis
5%
Seroprevalence
5%
Severe Acute Respiratory Syndrome Coronavirus 2
40%
Toxoplasmosis
5%
Vaccination Policy
7%
Vaccine Efficacy
21%
Viral Load
5%
Viremia
5%
